Select area to zoom
Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '25100.0090.04

Profile

Edit
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
URL https://www.veronapharma.com
Investor Relations URL https://www.veronapharma.com/investors
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Aug. 08, 2025 (est.)
Last Earnings Release Apr. 29, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
URL https://www.veronapharma.com
Investor Relations URL https://www.veronapharma.com/investors
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Aug. 08, 2025 (est.)
Last Earnings Release Apr. 29, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows